PHARMASIN 100 GRANULAR PREMIX

Land: Australien

Sprache: Englisch

Quelle: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Kaufe es jetzt

Herunterladen Gebrauchsinformation (PIL)
03-04-2018

Wirkstoff:

TYLOSIN AS THE PHOSPHATE

Verfügbar ab:

Huvepharma EOOD

INN (Internationale Bezeichnung):

tylosin as phosphate(100g/kg)

Darreichungsform:

ORAL POWDER, PRE-MIX

Zusammensetzung:

TYLOSIN AS THE PHOSPHATE ANTIBIOTIC Active 100.0 g/kg

Einheiten im Paket:

20kg; 5kg

Klasse:

VM - Veterinary Medicine

Therapiegruppe:

BROILER | CATTLE | PIGS | POULTRY - SEE LABEL | BEEF | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CAL

Therapiebereich:

ANTIBIOTIC & RELATED

Anwendungsgebiete:

ENTERIC DISEASES SUSCEPTIBLE TO TYLOSIN | ILEITIS | IMPROVE FEED EFFICIENCY | LIVER ABSCESS | NECROTIC ENTERITIS - AID IN PREVENTION | PROMOTE ANIMAL GROWTH | SWINE DYSENTERY | FEED CONVERSION | FINISHING | GROWTH PROMOTION | GROWTH RATE | LIVEWEIGHT GAIN

Produktbesonderheiten:

Poison schedule: 4; Withholding period: WHP: Meat[pigs cattle poultry]:Nil Milk: Nil Eggs: Nil ESI: This product does not have and ESI established.; Host/pest details: BROILER: [NECROTIC ENTERITIS - AID IN PREVENTION]; CATTLE: [LIVER ABSCESS]; PIGS: [ENTERIC DISEASES SUSCEPTIBLE TO TYLOSIN, ILEITIS, SWINE DYSENTERY]; POULTRY - SEE LABEL: [NECROTIC ENTERITIS - AID IN PREVENTION]; Poison schedule: 4; Withholding period: ; Host/pest details: BROILER: [NECROTIC ENTERITIS - AID IN PREVENTION]; CATTLE: [LIVER ABSCESS]; PIGS: [ENTERIC DISEASES SUSCEPTIBLE TO TYLOSIN, ILEITIS, SWINE DYSENTERY]; POULTRY - SEE LABEL: [NECROTIC ENTERITIS - AID IN PREVENTION]; An aid in controlling enteric diseases susceptible to tylosin and aid in stimulating growth and improving feed conversion efficiency in pigs. Treat and prevent ileitis in pigs. Reduce in incidence of liver abscesses in cattle. Aid control of necrotic ….

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2023-07-01

Gebrauchsinformation

                                PRODUCT NAME: Pharmasin 100 Granular Premix Page 1 of 4
Company Name:
Huvepharma EOOD
Product Name:
PHARMASIN 100 Granular Premix
APVMA Approval No:
61977/RV0318M
Label Name:
PHARMASIN 100 Granular Premix
Signal Headings:
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF
REACH
OF
CHILDREN
FOR
ANIMAL
TREATMENT
ONLY
READ
SAFETY
DIRECTIONS
BEFORE
OPENING
OR
USING
Constituent
Statements:
100g/kg TYLOSIN as the phosphate.
Claims:
For use as an aid in controlling enteric diseases susceptible to
tylosin in pigs.
For the treatment and prevention of ileitis in pigs.
For reduction in the incidence of liver abscesses in cattle.
As an aid in the control of necrotic enteritis caused by
Clostridium perfringens
in
broiler and replacement chickens.
Net Contents:
5kg/20kg NET
Directions for Use:
Refer to Page 3.
Restraints:
‘
Prior to prescribing PHARMASIN 100 Granular Premix investigate the use
of
non-antibiotic options. If PHARMASIN 100 Granular Premix is indicated
and
selected for use, prudent prescribing practices (appropriate dose,
duration and
frequency to minimise treatment failure while minimising the emergence
of
antimicrobial resistance) must be adhered to.
NOT TO BE USED FOR ANY PURPOSE, OR IN ANY MANNER, CONTRARY
TO THIS LABEL.
’
Contraindications:
Precautions: RLP APPROVED
PRODUCT NAME: Pharmasin 100 Granular Premix Page 2 of 4
Side
Effects:
Dosage and
Administration:
Refer to Page 3.
General
Directions:
For use in pig, cattle and poultry feed only.
Withholding
Periods:
MEAT [pigs, cattle, poultry]: NIL
MILK: NIL
EGGS: NIL
Trade
Advice:
EXPORT SLAUGHTER INTERVAL (ESI): This product does not have an
ESI established. For advice on the ESI, contact the manufacturer on
(02) 9810 1104 before using this product.
Safety
Directions:
Harmful if swallowed. Will irritate the eyes and skin. Avoid contact
with eyes and
skin. Repeated exposure may cause allergic disorders. Do not inhale
dust When
opening the container and mixing into premixes wear cotton overalls
buttoned to
the neck and wrist and a washable hat, elbow length PVC gloves 
                                
                                Lesen Sie das vollständige Dokument